Essenlix Partners with Roche Diagnostics Norway to Employ Essenlix’s iMOST platform represents

PRINCETON, N.J., May 20, 2021 /PRNewswire/ — Essenlix Corporation, a premier developer, manufacturer, and provider of mobile instant health test solutions for personal, point-of-care, and clinical use using disruptive and proprietary advanced technology, today announced that it is partnering with Roche Diagnostics Norway to implement Essenlix’s iMOST^TM platform for the Patient At-Home Test market.

Related Links